[ad_1]
Amgen (AMGN) posted second quarter income of $8.4 billion, coming in barely above the estimated $8.34 billion. Nevertheless, the pharmaceutical firm missed on adjusted earnings expectations by only a hair, coming in at $4.97 per share as an alternative of $4.98.
Yahoo Finance Senior Reporter Anjalee Khemlani digs into the earnings report and the way its weight problems drug MariTide might present an earnings increase down the road if accepted.
For extra professional perception and the newest market motion, click on here to observe this full episode of Market Domination Additional time.
This publish was written by Melanie Riehl
[ad_2]
Source
